Our aims
Philosophy
Understanding the importance of protein synthesis dysregulation in cancer
Objectives
Promoting multiple cross-disciplinary research partnerships
Capacity Building
Strengthen scientific interactions among experts across Europe with complementary skills
State of the art
Dysregulated translation in cancer exposes vulnerabilities that are amenable to targeted therapies.
Upcoming events in Translacore
View all eventsPeople involved in Translacore
View all membersUpcoming events outside Translacore
View all eventsYou might also like
Translacore open database

Job offer in molecular biology and structural biology for PhD student
Job offer in molecular biology and structural biology. PhD-STUDENT SCHOLARSHIP (for a period of 25 months, with the possibility of extension by 1 year or more) in the field of biochemistry, biophysics and structural biology at the Department of Molecular Biology, University of Maria Curie-Skłodowska, Lublin, Poland
Biotechnology Engineer in Oncology
The position is part of an INCa-funded project to study the impact of chemotherapies on protein synthesis and tumor cell plasticity. It is located at the Centre de Recherche en Cancérologie de Lyon (CRCL) (directed by P Mehlen), an internationally renowned center dedicated to innovative oncology research (www.crcl.fr). The engineer will be integrated into the “Ribosome, Translation and Cancer” team, headed by Dr. Jean-Jacques Diaz. The team explores the role of protein synthesis and ribosomes in tumor pathology. --> Deadline for application, 15 May 2025

Post-Doctoral Position in the field of Protein Synthesis, Stem Cells and Colorectal Cancer
The Department of Physiological Sciences, University of Barcelona is looking for a highly motivated Post-doctoral Researcher for a full-time position at the Pelletier lab, Department of Physiological Sciences, University of Barcelona. We investigate how protein synthesis and translational control contribute to tumor heterogeneity and plasticity in Colorectal Cancer (CRC). The position involves working with advanced genetically engineered mouse models and patient-derived colorectal cancer organoids to explore the role of translational control in the plasticity of CRC cells. Please find more information attached.